AmerisourceBergen Still Bullish On Medicare Rx; Part B Changes Pinch
Executive Summary
AmerisourceBergen expects to feel a negative impact from the changes in oncology reimbursement under Medicare Part B in 2005
You may also be interested in...
Bristol Exiting Oncology Distribution Business Ahead Of Part B Pinch
Bristol-Myers Squibb has signed an agreement to sell its Oncology Therapeutics Network unit prior to the 2005 reimbursement changes for chemotherapy drugs under the Medicare Rx law
Bristol Exiting Oncology Distribution Business Ahead Of Part B Pinch
Bristol-Myers Squibb has signed an agreement to sell its Oncology Therapeutics Network unit prior to the 2005 reimbursement changes for chemotherapy drugs under the Medicare Rx law
ABC Goes To D.C.: Former Amgen Exec Norton Will Head Government Affairs
AmerisourceBergen is opening a Washington, D.C. government affairs office led by former Amgen VP Rita Norton